Concourse Financial Group Securities’s Alexion Pharmaceuticals ALXN Stock Holding History

Concourse Financial Group Securities’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-105	Closed	-$19K	–	10370
2021 Q2	$19K	Sell	105 -29	-22%	-$4.98K	﹤0.01%	1673
2021 Q1	$20K	Sell	134 -189	-59%	-$29.2K	﹤0.01%	1575
2020 Q4	$50K	Buy	323 +13	+4%	+$1.67K	﹤0.01%	1156
2020 Q3	$35K	Buy	310 +108	+53%	+$11.7K	﹤0.01%	1187
2020 Q2	$23K	Sell	202 -1,707	-89%	-$181K	﹤0.01%	1258
2020 Q1	$171K	Buy	+1,909	New	+$187K	0.02%	505
2019 Q2	–	Sell	-544	Closed	-$70.1K	–	6853
2019 Q1	$73K	Buy	544 +336	+162%	+$41.8K	0.01%	758
2018 Q4	$20K	Buy	208 +13	+7%	+$1.54K	﹤0.01%	1162
2018 Q3	$27K	Buy	+195	New	+$24.5K	0.01%	773

Other funds holding ALXN

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return